Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,256,225 papers from all fields of science
Search
Sign In
Create Free Account
EP 217609
Known as:
EP-217609
, EP217609
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Biotin
Oligosaccharides
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
First in man study of EP217609, a new long-acting, neutralisable parenteral antithrombotic with a dual mechanism of action
P. Guéret
,
S. Combe
,
+4 authors
E. Neuhart
European Journal of Clinical Pharmacology
2016
Corpus ID: 15427935
EP217609 is a parenteral antithrombotic compound combining in one molecule an indirect anti-factor Xa inhibitor, a direct…
Expand
2016
2016
Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study
P. Guéret
,
S. Combe
,
+4 authors
E. Neuhart
European Journal of Clinical Pharmacology
2016
Corpus ID: 23986008
IntroductionEP217609 is a representative of a new class of synthetic parenteral anticoagulants with a dual mechanism of action…
Expand
2016
2016
Neutralization of EP217609, a new dual-action FIIa/FXa anticoagulant, by its specific antidote avidin: a phase I study
P. Guéret
,
S. Combe
,
+4 authors
E. Neuhart
European Journal of Clinical Pharmacology
2016
Corpus ID: 253769419
EP217609 is a representative of a new class of synthetic parenteral anticoagulants with a dual mechanism of action. It combines…
Expand
Review
2015
Review
2015
Les différentes alternatives d’anticoagulation au couple héparine/protamine en chirurgie cardiaque sous circulation extra-corporelle
A. Bouraghda
,
P. Gillois
,
P. Albaladéjo
2015
Corpus ID: 115372314
RésuméObjectifL’héparine et la protamine constituent la stratégie d’anticoagulation de référence en chirurgie cardiaque sous…
Expand
Review
2015
Review
2015
Alternatives to heparin and protamine anticoagulation for cardiopulmonary bypass in cardiac surgery
A. Bouraghda
,
P. Gillois
,
P. Albaladéjo
Canadian Journal of Anesthesia/Journal canadien d…
2015
Corpus ID: 10908184
Heparin anticoagulation followed by protamine reversal is commonly used in cardiopulmonary bypass (CPB) cardiac procedures, but…
Expand
2014
2014
EP217609, a neutralisable dual-action FIIa/FXa anticoagulant, with antithrombotic effects in arterial thrombosis
Ghina Alamé
,
P. Mangin
,
+5 authors
C. Gachet
Thrombosis and Haemostasis
2014
Corpus ID: 29409916
Summary EP217609 is a new synthetic parenteral dual-action anticoagulant combining a direct thrombin inhibitor (α-NAPAP analog…
Expand
Review
2009
Review
2009
From heparin to EP217609: The long way to a new pentasaccharide-based neutralisable anticoagulant with an unprecedented pharmacological profile
M. Petitou
,
V. Nancy-Portebois
,
+6 authors
Jeffry A J Wisse
Thrombosis and Haemostasis
2009
Corpus ID: 3289389
Summary The elucidation of the structure of the antithrombin binding sequence in heparin has given a large impulse to the…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE